
HLM Venture Partners
Description
HLM Venture Partners is a well-established venture capital firm based in Boston, Massachusetts, with a specialized focus on growth equity investments within the dynamic healthcare sector. Since its inception in 1987, the firm has primarily targeted companies leveraging technology to innovate and transform healthcare delivery, efficiency, and patient outcomes. Their investment scope broadly covers healthcare information technology, digital health solutions, and various healthcare services, seeking out businesses poised for significant expansion and market disruption.
The firm typically engages with companies at their growth stages, providing capital to scale operations, expand market reach, and accelerate product development. HLM Venture Partners is known for deploying initial checks that generally range from $5 million to $20 million, often participating in larger funding rounds alongside co-investors. Their portfolio reflects a commitment to companies that are not only technologically advanced but also possess strong management teams and clear pathways to market leadership. For instance, their HLM Venture Partners VII fund, closed in 2017, secured $200 million, underscoring their substantial capital base for these investments.
Beyond financial backing, HLM Venture Partners emphasizes a hands-on approach, leveraging its extensive industry expertise and deep network to support portfolio companies. The team comprises professionals with significant operational and investment experience in healthcare, offering strategic guidance, business development support, and access to key industry relationships. This value-add approach aims to foster sustainable growth and maximize the potential for successful exits. Over its history, the firm has made over 100 investments and facilitated more than 30 exits, demonstrating a consistent track record in the healthcare investment landscape.
Investor Profile
HLM Venture Partners has backed more than 133 startups, with 0 new investments in the last 12 months alone. The firm has led 38 rounds, about 29% of its total and boasts 47 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series Unknown, Series C, Series B rounds (top funding stages).
- Majority of deals are located in United States, Canada, Denmark.
- Strong thematic focus on Health Care, Medical, Information Technology.
- Typical check size: $5M – $20M.
Stage Focus
- Series Unknown (26%)
- Series C (23%)
- Series B (17%)
- Series D (15%)
- Series A (11%)
- Series E (3%)
- Debt Financing (2%)
- Seed (2%)
- Post Ipo Equity (1%)
- Pre Seed (1%)
Country Focus
- United States (96%)
- Canada (2%)
- Denmark (1%)
- India (1%)
Industry Focus
- Health Care
- Medical
- Information Technology
- Software
- Biotechnology
- Hospital
- Medical Device
- Mhealth
- Pharmaceutical
- Enterprise Software
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.